International Cholangiocarcinoma Research Network (ICRN)

The International Cholangiocarcinoma Research Network (ICRN) concept was introduced by members of the CCF’s Medical, Clinical, and Basic Science Advisory Boards during the Cholangiocarcinoma Foundation Annual Meeting in Salt Lake City, Utah in February 2015.
The ICRN is a global collaboration of research groups from renowned institutions that are working in concert to improve knowledge about cholangiocarcinoma etiology, prevention, early detection, treatment and prognosis. The network is comprised of highly talented individuals from a spectrum of disciplines, perspectives, and research methods who share the passion to make significant scientific advances that improve outcomes for patients with cholangiocarcinoma.
In March of 2017, several representatives from the Cholangiocarcinoma Foundation attended the first Asia-Pacific Conference in Bangkok, Thailand.

The goal of ICRN is to accelerate the clinical translation of scientific discoveries to impact the lives of patients with cholangiocarcinoma.

ICRN Members Map

International Cholangiocarcinoma Research Network (ICRN) Map

ICRN Executive Committee

Dr. Milind Javle

Milind Javle, MD


UT MD Anderson Cancer Center

Mitesh Borad, MD

Vice Chair

Mayo Clinic, Arizona


John Bridgewater, PhD

University College London Hospital, UK


Laura Goff, MD

Vanderbilt Ingram Cancer Center


Lewis Roberts, MB, ChB, PhD

Mayo Clinic, Minnesota


Virote Sriuranpong, MD, PhD

Chulalongkorn University

Advocacy Organization Hybrid Model for Advancing Research

Pin It on Pinterest